Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Product/R&D News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Expert Opinions
Case Studies
Company Profiles
Editor´s Picks
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Product/R&D News
Harbour BioMed Announces IND Approval for HBM9161 by NMPA 6/3/2020
Innovent Announces the Preliminary Results of the Anti-CTLA-4 Mon... 6/3/2020
Inventiva Secures A New Patent for lanifibranor in China 6/1/2020
Henlius and Accord Receive Positive CHMP Opinion for Biosimilar H... 6/1/2020
Chi-Med Plans to Submit NDA for Surufatinib Following Pre-NDA Mee... 6/1/2020
EMA Accepts First Application for Chinese-made Biosimilar HLX02 6/1/2020
Sino Biopharma and Akeso Files NDA for Penpulimab in China 5/26/2020
Chi-Med and BeiGene Partners to Evaluate Combos of Surufatinib an... 5/26/2020
Apollomics Announces Initiation of SPARTA P2 Trial for c-MET Inhi... 5/22/2020
Tyvyt Combined with Gemzar and Platinum Chemotherapy Met Endpoint... 5/19/2020
Chinese Scientists Test New Drug Candidate against Coronavirus 5/19/2020
GSK Granted Clinical Trial Approval of ICOS mAb with Keytruda for... 5/18/2020
Ascletis Granted Chinese Clinical Approval for NASH Indication of... 5/14/2020
Innovent/Eli Lilly Announce Positive Outcome of TYVYT (Sintilimab... 5/14/2020
Junshi Bio Announces Chinese sNDA for Toripalimab in Urothelial C... 5/8/2020
Zai Lab's NDA for Omadacycline Granted Priority Review by the CDE... 5/6/2020
Ascentage's HQP1351 Granted Orphan Drug Designation by the USFDA 5/5/2020
Chinese Seaweed Alzheimer's Drug Granted FDA Approval for Global ... (free) 4/29/2020
Innovent Announces First Patient Dosed in a Pivotal Trial of Pars... 4/27/2020
Roche's NDA for SMA Drug Risdiplam Accepted by the NMPA 4/25/2020
Innovent and Eli Lilly Announce sNDA Acceptance for Sintilimab in... 4/24/2020
Gilead Disputes WHO Report That Remdisivir Failed in China Trial 4/24/2020
Henlius and Accord Receive Positive CHMP Opinion for Oncology Bio... 4/23/2020
CStone's First Chinese NDA for Anticancer Avapritinib Accepted 4/23/2020
Everest Med Approved for Clinical Trial of Sacituzumab in China 4/23/2020
Innovent Biologics Announces USFDA Approval of Pemazyre (Pemigati... 4/22/2020
BeiGene's sNDA for Tislelizumab in Combo with NSCLC Chemotherapy ... 4/21/2020
Chi-Med's Surufatinib Granted US Fast Track Designations (free) 4/20/2020
Zai Lab Granted Priority Review of sNDA for ZEJULA (Niraparib) fo... 4/16/2020
Harbour BioMed Granted IND Approval to Begin Phase 2/3 Clinical T... 4/15/2020
Page:1/6    Total number of articles:161  :[1][2][3][4][5][>>][End]

© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links